Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Chugai Files NDA for a Renal Anemia Agent R744
Chugai Pharmaceutical Co., 08/24/09
Chugai Pharmaceutical Co., Ltd. announced that the company filed a new drug application for R744, a long–acting erythropoiesis–stimulating agent, for the treatment of anemia associated with chronic kidney disease with the Japanese Ministry of Health, Labour and Welfare today.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09
Article Search
Sponsor


See Latest Articles


